← Back to headlines
Rigel and Protagonist Therapeutics to Attend September Investor Conferences
Rigel Pharmaceuticals and Protagonist Therapeutics have announced plans to participate in upcoming investor and investment bank conferences scheduled for September. The events will provide platforms for management teams to present corporate updates and financial outlooks to market participants.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
